Skip to main content

Table 1 Baseline characteristics and treatment cycle variables of participants undergoing assisted reproductive treatments

From: Vitamin D and assisted reproductive treatment outcome: a prospective cohort study

Vitamin D Category

p-value

 

Deficienta

(< 50 nmol/L)

N = 266

Insufficienta

(50-75 nmol/L)

N = 154

Repletea

(> 75 nmol/L)

N = 80

Age -years(SD)

33.2 (4.9)

33.7 (4.4)

34.2 (4.6)

0.20

BMI (SD)

24.7 (4.0)

25.1 (3.6)

24.1 (3.1)

0.18

Ethnicity (%)

 White

93 (36.0)

101 (39.2)

64 (24.8)

< 0.001+

 South Asian

125 (71.8)

37 (21.3)

12 (6.9)

 Black

20 (66.7)

8 (26.7)

2 (6.6)

 Chinese

5 (62.5)

2 (25.0)

1 (12.5)

 Other

23 (76.7)

6 (20.0)

1 (3.3)

Season (%)

 Winter

76 (59.4)

41 (32.0)

11 (8.6)

< 0.001+

 Spring

77 (61.6)

39 (31.2)

9 (7.2)

 Summer

31 (31.0)

40 (40.0)

29 (29.0)

 Autumn

82 (55.8)

34 (23.1)

31 (21.1)

Smoking (%)

 Smokers

16 (6.0)

6 (3.9)

4 (5.0)

0.64+

Duration of infertility in months (Median-IQR)

48 (36–72)

36 (24–60)

36 (24–60)

0.04

Mean pituitary FSH (iU/ml) (SD)

7.9 (2.9)

7.6 (2.9)

7.9 (4.0)

0.73

Mean AMH (SD)

18.7 (21.7)

22.6 (27.4)

14.3 (14.1)

0.34

Previous live birth (%)

198 (80.5)

11 (78.7)

62 (80.5)

0.91+

Treatment type (%)

 IVF

99 (40.2)

54 (38.3)

40 (52.0)

0.37+

 ICSI

130 (52.9)

78 (55.3)

33 (42.9)

 FET

17 (6.9)

9 (6.4)

4 (5.1)

Number of embryos transferred at day 5 post oocyte retrieval (%)

97 (46.6)

65 (53.3)

40 (56.3)

0.28+

Number of embryos transferred (%)

 Single

153 (73.6)

79 (64.8)

51 (71.8)

0.23+

 Double

55 (26.4)

43 (35.2)

20 (28.2)

Top grade embryo transfer

169 (81.2)

93 (76.2)

56 (78.9)

0.55+

  1. aAs defined by Endocrine Society
  2. +p-value for chi2 test